Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Allergan reports new compounds acting as retinoid antagonists or inverse agonists

Dec. 30, 1998

Aged garlic extract: in vitro and in vivo antiallergic effects

Dec. 28, 1998

FDA accepts Hyal's NDA for Solarase

Dec. 23, 1998

Suppression of chemokine production contributes to beneficial dermal effects of tacalcitol

Dec. 22, 1998

Maxim advances development of MaxDerm topical treatment

Dec. 22, 1998

Angiotech initiates another clinical trial with paclitaxel for treatment of psoriasis

Dec. 16, 1998

Antipruritic, immunosuppressive MS-444 derivatives reported by Kyowa Hakko

Dec. 15, 1998

Thalidomide evaluated for toxic epidermal necrolysis and found detrimental

Dec. 10, 1998

Abgenix initiates a phase I/II clinical trial in patients with psoriasis

Dec. 3, 1998

Diane-35 now available in Canada for treatment of acne

Dec. 2, 1998

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...